Behavioral Health
Free course
Version 1.0
Audio version available

Frontotemporal Dementia: A Quick Overview

The purpose of this course is to provide healthcare professionals with an overview of frontotemporal dementia (FTD), and explore its symptoms, types, causes, diagnostics methods, treatment options, potential complications, management strategies, and nursing considerations to improve the quality of life for individuals affected by frontotemporal dementia.

Contact hours
4
Estimated time
60 minutes
Last reviewed

Free

Get Unlimited CE instead

Secure checkout. Certificates issue instantly and stay in your vault even after a subscription ends.

  • Post-test optional · 70% to pass · unlimited retakes

About this course

Dementia arises from a diverse array of diseases and injuries that affect the brain, causing cognitive decline and functional impairment. Frontotemporal Dementia (FTD) represents a distinct form of dementia, yet its recognition and understanding remain limited within the medical community. With an estimated prevalence of around 60,000 cases in the United States, FTD often eludes accurate diagnosis and is frequently mistaken for other conditions such as depression, Alzheimer's disease, Parkinson's disease, or psychiatric disorders. This course examines frontotemporal dementia in detail, exploring its presentation, types, causes, and diagnostics methods. It also explores current treatment options, potential complications, management strategies, and nursing considerations to improve the quality of life for individuals affected by frontotemporal dementia.

Learning objectives

  • Review factors that increase the risk of developing dementia.
  • Differentiate between the various types of frontotemporal dementia, including Behavioral variant frontotemporal dementia (bvFTD), Primary progressive aphasia (PPA) and Movement disorders.
  • Understand the factors that increase the likelihood of developing frontotemporal dementia.
  • Review treatment and management option for frontotemporal dementia.
  • Understand nursing considerations when caring for patients with frontotemporal dementia, and resources available for family members.

Course outline

15 sections · finish in any order across devices

  1. 1

    Introduction

    Dementia is a pressing global health issue affecting millions of individuals worldwide. Currently, more than 55 million people live with dementia, with over 60% residing in low- and middle-income countries. Each year, an estimated 10 million new cases of dementia emerge, contributing to the escalati

    4 min

  2. 2

    Overview of Dementia

    Dementia is a complex syndrome characterized by the progressive deterioration of cognitive functions caused by damage to nerve cells and impairments in brain function. While aging may lead to cognitive decline, dementia represents a significant departure from typical age-related changes, affecting m

    4 min

  3. 3

    Definition of Frontotemporal Dementia

    Frontotemporal dementia (FTD), also known as frontotemporal lobar degeneration (FTLD) or Pick's disease, is a type of dementia characterized by the degeneration of neurons in the brain’s frontal and temporal lobes. The frontal lobe, the largest lobe of the brain, resides in front of the cerebral hem

    4 min

  4. 4

    Behavioral Variant Frontotemporal Dementia

    Behavioral variant frontotemporal dementia (bvFTD) is the most prevalent form of FTD. It accounts for approximately half of all cases of the disease. Unlike Alzheimer's disease, where memory impairment is a prominent feature, bvFTD primarily manifests through changes in personality, behavior, and ju

    4 min

  5. 5

    Primary Progressive Aphasia

    Primary progressive aphasia (PPA) encompasses a spectrum of language-related impairments that affect the ability to speak, read, write, and understand spoken language. It is characterized by a gradual decline in language abilities, which may include difficulty in using or comprehending words (aphasi

    4 min

  6. 6

    Movement Disorders

    Movement disorders associated with FTD include two rare neurological conditions that affect the regions of the brain responsible for controlling movement:

    4 min

  7. 7

    Causes of Frontotemporal Dementia

    Frontotemporal dementia can arise from various underlying causes, contributing to the diverse manifestations of the condition. Primary causes of FTD have been linked to genetic factors, protein abnormalities, neuronal degeneration, and environmental factors. Approximately 10% of all cases of FTD hav

    4 min

  8. 8

    Risk Factors for Frontotemporal Dementia

    Several risk factors have been identified that may increase the likelihood of developing FTD, including genetic predisposition, age, gender, history of head trauma, environmental exposure, and lifestyle choices. Family history plays a significant role in FTD risk, with certain genetic mutations stro

    4 min

  9. 9

    Diagnosis of Frontotemporal Dementia

    Diagnosing FTD is inherently complex, especially during the early stages of the disease. The challenge primarily stems from the diverse and often subtle array of symptoms exhibited by individuals with FTD, which can overlap with those of other neurodegenerative disorders including Alzheimer's diseas

    4 min

  10. 10

    Treatment Options

    Currently, there is no cure for any type of FTD, and in most cases, particularly for bvFTD, treatment options are limited, and progression cannot be slowed. Therefore, interventions focus primarily on managing symptoms and improving the quality of life for patients and their caregivers. Non-pharmaco

    4 min

  11. 11

    Potential Complications

    Frontotemporal dementia often leads to a spectrum of complications that significantly affect the individual's daily life and overall health. Most notable is the increased risk of accidents and injuries. Due to behavioral changes associated with FTD, such as impulsivity, disinhibition, and poor judgm

    4 min

  12. 12

    Management Strategies

    Given the complex nature of FTD and its potential complications, a comprehensive approach to care is essential. This approach involves multidisciplinary collaboration among healthcare professionals to address the diverse needs of individuals with FTD and provide tailored support and interventions. M

    4 min

  13. 13

    Family and Caregiver Considerations

    For caregivers and family members of individuals diagnosed with FTD, navigating the challenges of caregiving requires patience and a deep understanding of the condition's progressive nature. To provide optimal care, family and caregivers need to fully understand the disease's symptoms, stages, and p

    4 min

  14. 14

    Nursing Considerations

    Several key considerations are vital to ensuring comprehensive and effective care delivery in nursing care for individuals with FTD. Regular and thorough assessments of behavioral and cognitive changes are essential for early detection of FTD progression and the development of appropriate care inter

    4 min

  15. 15

    Conclusion

    Frontotemporal dementia (FTD) is a multifaceted neurodegenerative condition characterized by the progressive degeneration of neurons in the brain’s frontal and temporal lobes. Accurate diagnosis of FTD requires a comprehensive evaluation of clinical symptoms, cognitive function, behavioral changes,

    4 min

This course satisfies

    Requirement summaries come from our state requirement records. Always confirm details with your board before you renew.

    References and resources

    • Dementia. (n.d.). Www.who.int. Retrieved March 8, 2024, from https://www.who.int/news-room/fact-sheets/detail/dementia/?gad_source=1&gclid=CjwKCAiA6KWvBhAREiwAFPZM7iLtXI9IHou9SYl_huFAok9Pzn2VoYoAryiEo4r9egvi9hOxaMLEkhoC1dkQAvD_BwE
    • CDC. (2019, April 5). What Is dementia? Centers for Disease Control and Prevention. https://www.cdc.gov/aging/dementia/index.html
    • Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and Management of Dementia: A Review. JAMA, 322(16), 1589. https://doi.org/10.1001/jama.2019.4782
    • Duong, S., Patel, T., & Chang, F. (2017). Dementia: What pharmacists need to know. Canadian Pharmacists Journal : CPJ, 150(2), 118-129. https://doi.org/10.1177/1715163517690745
    • Young, J. J., Lavakumar, M., Tampi, D., Balachandran, S., & Tampi, R. R. (2017). Frontotemporal dementia: Latest evidence and clinical implications. Therapeutic Advances in Psychopharmacology, 8(1), 33-48. https://doi.org/10.1177/2045125317739818
    • American Association of Neurological Surgeons. (2019). A Neurosurgeon’s Overview of the Brain’s Anatomy. Aans.org. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Anatomy-of-the-Brain
    • Cerebrum - an overview | ScienceDirect Topics. (2012). Sciencedirect.com. https://www.sciencedirect.com/topics/neuroscience/cerebrum
    • Herbet, G., & Duffau, H. (2020). Revisiting the Functional Anatomy of the Human Brain: Toward a Meta-Networking Theory of Cerebral Functions. Physiological Reviews, 100(3), 1181–1228. https://doi.org/10.1152/physrev.00033.2019
    • Frontotemporal Dementia and Other Frontotemporal Disorders | National Institute of Neurological Disorders and Stroke. (n.d.). Www.ninds.nih.gov. https://www.ninds.nih.gov/health-information/disorders/frontotemporal-dementia-and-other-frontotemporal-disorders
    • What is FTD? (n.d.). AFTD. https://www.theaftd.org/what-is-ftd/disease-overview/
    • What is BvFTD? (Behavioral Variant FTD), Pick’s Disease. (n.d.). AFTD. https://www.theaftd.org/what-is-ftd/behavioral-variant-ftd-bvftd/
    • Primary Progressive Aphasia (PPA) | AFTD. (2019, February 5). https://www.theaftd.org/what-is-ftd/ftd-disorders/primary-progressive-aphasia/
    • Nonfluent/Agrammatic PPA (Primary Progressive Aphasia) | AFTD. (2018, March 2). https://www.theaftd.org/what-is-ftd/primary-progressive-aphasia/nonfluent-agrammatic-ppa-nfvppa/
    • Semantic Variant PPA (Primary Progressive Aphasia). (n.d.). AFTD. https://www.theaftd.org/what-is-ftd/primary-progressive-aphasia/semantic-variant-ppa-svppa/
    • Logopenic Variant PPA (Primary Progressive Aphasia) | AFTD. (2018, March 2). https://theaftd.org/what-is-ftd/primary-progressive-aphasia/logopenic-variant-ppa/
    • Corticobasal Syndrome - Frontotemporal Degeneration | AFTD. (2018, March 2). https://www.theaftd.org/what-is-ftd/corticobasal-syndrome/
    • Progressive Supranuclear Palsy | AFTD. (2018, March 2). AFTD. https://www.theaftd.org/what-is-ftd/progressive-supranuclear-palsy/
    • ALS and Frontotemporal Degeneration | AFTD. (2011). AFTD. https://www.theaftd.org/what-is-ftd/ftd-and-als-ftd-als/
    • Olszewska, D. A., Lonergan, R., Fallon, E. M., & Lynch, T. (2016). Genetics of Frontotemporal Dementia. Current Neurology and Neuroscience Reports, 16(12). https://doi.org/10.1007/s11910-016-0707-9
    • Currens, L., Harrison, N., Schmidt, M., Amjad, H., Mu, W., Scholz, S. W., Bang, J., & Pantelyat, A. (2023). A case of familial frontotemporal dementia caused by a progranulin gene mutation. Clinical Parkinsonism & Related Disorders, 9. https://doi.org/10.1016/j.prdoa.2023.100213
    • Eid, H. R., Rosness, T. A., Bosnes, O., Salvesen, Ø., Knutli, M., & Stordal, E. (2019). Smoking and Obesity as Risk Factors in Frontotemporal Dementia and Alzheimer's Disease: The HUNT Study. Dementia and Geriatric Cognitive Disorders EXTRA, 9(1), 1-10. https://doi.org/10.1159/000495607
    • Soppela, H., Katisko, K., Gadola, Y., Krüger, J., Hartikainen, P., Alberici, A., Benussi, A., Koivisto, A., Haapasalo, A., Remes, A. M., Borroni, B., & Solje, E. (2022). Modifiable potential risk factors in familial and sporadic frontotemporal dementia. Annals of Clinical and Translational Neurology, 9(8), 1195-1205. https://doi.org/10.1002/acn3.51619
    • Bott, N. T., Radke, A., Stephens, M. L., & Kramer, J. H. (2014). Frontotemporal dementia: Diagnosis, deficits, and management. Neurodegenerative Disease Management, 4(6), 439. https://doi.org/10.2217/nmt.14.34
    • Boeve, B. F., Boxer, A. L., Kumfor, F., Pijnenburg, Y., & Rohrer, J. D. (2022). Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. The Lancet Neurology, 21(3), 258–272. https://doi.org/10.1016/s1474-4422(21)00341-0
    • Tsai, R. M., & Boxer, A. L. (2014). Treatment of Frontotemporal Dementia. Current Treatment Options in Neurology, 16(11), 319. https://doi.org/10.1007/s11940-014-0319-0
    • Magrath Guimet, N., Zapata-Restrepo, L. M., & Miller, B. L. (2022). Advances in Treatment of Frontotemporal Dementia. The Journal of Neuropsychiatry and Clinical Neurosciences, 34(4), 316–327. https://doi.org/10.1176/appi.neuropsych.21060166
    • Caceres, B. A., Frank, M. O., Jun, J., Martelly, M. T., Sadarangani, T., & De Sales, P. C. (2016). Family caregivers of patients with frontotemporal dementia: An integrative review. International Journal of Nursing Studies, 55, 71-84. https://doi.org/10.1016/j.ijnurstu.2015.10.016
    • Sagbakken, M., Nåden, D., Ulstein, I., Kvaal, K., Langhammer, B., & Rognstad, M.-K. (2017). Dignity in people with frontotemporal dementia and similar disorders — a qualitative study of the perspective of family caregivers. BMC Health Services Research, 17(1). https://doi.org/10.1186/s12913-017-2378-x
    • Rasmussen, H., Hellzen, O., Stordal, E., & Enmarker, I. (2019). Family caregivers experiences of the pre-diagnostic stage in frontotemporal dementia. Geriatric Nursing, 40(3), 246-251. https://doi.org/10.1016/j.gerinurse.2018.10.006

    Update history

      Take this course and the rest of the library

      Unlimited annual access covers every course, every state you track, and your certificates forever.

      Get Unlimited CE

      Still have a question? Ask our CE assistant

      Ask by voice or text about requirements, courses, pricing or your license — you get an answer instantly.

      Ask us — instant answer
      Ask anything about your license

      Type or tap the mic and speak — ask about your state's requirements, any course, your license type or pricing, and you get an answer right away.